Sfoglia per AUTORE
PANéS J
Collezione AO Ordine Mauriziano
Items : 3
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial. in The lancet. Gastroenterology & hepatology / Lancet Gastroenterol Hepatol. 2023 Jan;8(1):43-55. doi: 10.1016/S2468-1253(22)00303-X. Epub 2022 Oct
2023
AO Ordine Mauriziano
AO Ordine Mauriziano
Rydzewska G; Panaccione R; Baía C; Atreya R; Laharie D; Valentine JF; Jacob-Moffatt R; Eden C; Daperno M; Hassanali A; Sharafali Z; Danese S; Sandborn WJ; Panés J; Aguilar H; Vermeire S;
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial. in The lancet. Gastroenterology & hepatology / Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 F
2022
AO Ordine Mauriziano
AO Ordine Mauriziano
Danese S; Vermeire S; D'Haens G; Panés J; Dignass A; Magro F; Nazar M; Le Bars M; Lahaye M; Ni L; Bravata I; Lavie F; Daperno M; Lukáš M; Armuzzi A; Löwenberg M; Gaya DR; Peyrin-Biroulet L;
Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease. in Journal of Crohn's & colitis / J Crohns Colitis. 2011 Oct;5(5):484-98. doi: 10.1016/j.crohns.2011.07.003. Epub 2011 Aug 11.
2011
AO Ordine Mauriziano
AO Ordine Mauriziano
Daperno M; Castiglione F; de Ridder L; Dotan I; Färkkilä M; Florholmen J; Fraser G; Fries W; Hebuterne X; Lakatos PL; Panés J; Rimola J; Louis E;